Post
POST NYSE Packaged Foods & Meats Financials FY2016βFY2025
Post's revenue rose 3.0% to $8.2 billion in fiscal 2025. Its operating margin was 9.8%, down from 10.0% a year earlier. Free cash flow was $488 million, down 2.8%. It paid out $709 million in dividends and buybacks, 145% of free cash flow. The diluted share count fell 6.0%.
What Post does
No business description yet.
- Legal name
- Post Holdings, Inc.
- Fiscal year ends
- September 30, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001530950-25-000260
0001530950
Revenue and margins
Post had $8.2B of revenue in fiscal 2025, up 3.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $488M in fiscal 2025, 6.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Post returned $709M to shareholders in fiscal 2025, 145% of free cash flow. The diluted share count fell 6.0%.
Value Post yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$7.3B and divides by 62.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 14.7x Β· peers 22.6x Β· sector 24.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Post can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $665M | $587M | $93.3M | $787M | $177M |
| Debt incl. finance leases | $6.4B | $6.0B | $6.0B | $6.8B | $7.5B |
| Net debt / EBITDA | 6.8x | 6.8x | 5.9x | 4.8x | 5.5x |
| Debt / equity | 2.4x | 1.8x | 1.6x | 1.7x | 2.0x |
| Interest coverage | 1.5x | 1.3x | 2.2x | 2.5x | 2.2x |
| Current ratio | 2.0x | 2.7x | 1.8x | 2.4x | 1.7x |
| Quick ratio | 1.5x | 2.0x | 0.9x | 1.6x | 1.0x |
| Total assets | $12.4B | $11.3B | $11.6B | $12.9B | $13.5B |
| Total liabilities | $9.4B | $7.7B | $7.8B | $8.8B | $9.8B |
| Shareholders' equity | $2.7B | $3.3B | $3.8B | $4.1B | $3.8B |
| Net debt (β = net cash) | $5.8B | $5.4B | $6.0B | $6.1B | $7.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.2M
1 insider
Sold, 12 months
$34.9M
4 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | William P StiritzChairman Emeritus | Sold | 277,935 | $84.23 | $23.4M | Form 4 |
| Sep 1, 2026 | William P StiritzChairman Emeritus | Sold | 106,197 | $83.60 | $8.9M | Form 4 |
| May 13, 2026 | Gregory L CurlDirector | Sold | 6,186 | $105.05 | $0.6M | Form 4 |
| Feb 9, 2026 | Gregory L CurlDirector | Sold | 6,983 | $114.31 | $0.8M | Form 4 |
| Dec 5, 2025 | Bradly A HarperSVP, Chief Accting Officer | Sold | 1,658 | $96.69 | $0.2M | Form 4 |
| Nov 25, 2025 | Nicolas CatoggioPres & CEO, Pcb | Sold | 10,000 | $100.21 | $1.0M | Form 4 |
| Nov 24, 2025 | David W KemperDirector | Bought | 1,800 | $97.93 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 9 | 8 / 9 | 4 / 9 |
| Accruals ratio | β3.9% | β4.6% | β5.0% |
| Altman Z'' | 1.64 | 2.02 | 1.71 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Post POST | $4.1B | 3.0% | 9.8% | 6.0% | 5.7% | 14.7x | 4 | |
| J.M. Smucker SJM | β | 3.7% | 4.0% | 12.8% | 2.2% | 60.7x | β | Compare β |
| McCormick MKC | $13.0B | 1.7% | 15.7% | 10.8% | 8.7% | 8.7x | 6 | Compare β |
| Campbell's CPB | $6.2B | β5.0% | 8.7% | 7.0% | 6.2% | 15.8x | 5 | Compare β |
| Lamb Weston LW | $7.4B | 2.5% | 8.9% | 8.2% | 7.1% | 29.4x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $5.0B | $5.2B | $6.3B | $5.7B | $4.7B | $5.0B | $5.9B | $7.0B | $7.9B | $8.2B |
| Gross profit | $1.5B | $1.6B | $1.9B | $1.8B | $1.4B | $1.4B | $1.5B | $1.9B | $2.3B | $2.3B |
| Research and development | $16.3M | $18.6M | $25.1M | $25.0M | $19.1M | $21.9M | $18.9M | $22.9M | $29.0M | $31.9M |
| Operating income | $546M | $517M | $574M | $781M | $537M | $488M | $416M | $599M | $794M | $799M |
| Interest expense | $307M | $315M | $387M | $322M | $334M | $333M | $318M | $279M | $317M | $361M |
| Pretax income | β$30.1M | $74.4M | $265M | $159M | β$45.9M | $214M | $895M | $413M | $472M | $444M |
| Income tax | β$26.8M | $26.1M | β$204M | β$3.9M | β$21.3M | $58.2M | $85.7M | $99.7M | $105M | $109M |
| Net income | β$3.3M | $48.3M | $467M | $125M | $0.8M | $167M | $757M | $301M | $367M | $336M |
| Diluted EPS | β$0.41 | $0.50 | $6.16 | $1.66 | $0.01 | $2.38 | $12.09 | $4.82 | $5.64 | $5.51 |
| Diluted shares | 0.07B | 0.07B | 0.08B | 0.08B | 0.07B | 0.07B | 0.06B | 0.07B | 0.07B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $502M | $387M | $719M | $688M | $626M | $588M | $383M | $750M | $932M | $998M |
| Capital expenditure | $122M | $190M | $225M | $274M | $233M | $191M | $255M | $303M | $430M | $510M |
| Free cash flow | $381M | $196M | $494M | $414M | $393M | $397M | $127M | $447M | $502M | $488M |
| Depreciation and amortization | $303M | $323M | $398M | $380M | $345M | $367M | $380M | $407M | $477M | $524M |
| Stock-based compensation | $17.2M | $23.6M | $30.9M | $38.9M | $43.3M | $48.7M | $65.8M | $77.2M | $84.4M | $81.6M |
| Acquisitions | $94.4M | $1.9B | $1.5B | $0.0M | $19.9M | $290M | $24.8M | $715M | $248M | $920M |
| Share buybacks | $0.0M | $318M | $219M | $322M | $589M | $397M | $443M | $387M | $301M | $709M |
| Dividends paid | $14.4M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $14.4M | $318M | $219M | $322M | $589M | $397M | $443M | $387M | $301M | $709M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.1B | $1.5B | $990M | $1.1B | $1.2B | $665M | $587M | $93.3M | $787M | $177M |
| Total debt | $4.6B | $7.2B | $7.3B | $7.1B | $7.0B | $6.4B | $6.0B | $6.0B | $6.8B | $7.5B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $2.1B | $2.6B | $2.2B | $2.1B | $2.3B | $2.1B | $2.2B | $1.5B | $2.2B | $2.0B |
| Current liabilities | $634M | $704M | $792M | $803M | $974M | $1.0B | $824M | $805M | $945M | $1.2B |
| Inventory | $503M | $574M | $484M | $580M | $599M | $477M | $549M | $790M | $754M | $875M |
| Property and equipment, net | $1.4B | $1.7B | $1.7B | $1.7B | $1.8B | $1.8B | $1.8B | $2.0B | $2.3B | $2.7B |
| Total assets | $9.4B | $11.9B | $13.1B | $12.0B | $12.1B | $12.4B | $11.3B | $11.6B | $12.9B | $13.5B |
| Total liabilities | $6.4B | $9.1B | $10.0B | $9.0B | $9.3B | $9.4B | $7.7B | $7.8B | $8.8B | $9.8B |
| Shareholders' equity | $3.0B | $2.8B | $3.1B | $2.9B | $2.9B | $2.7B | $3.3B | $3.8B | $4.1B | $3.8B |
| Margins | ||||||||||
| Gross margin | 30.8% | 30.1% | 29.6% | 31.5% | 30.8% | 28.7% | 25.1% | 26.9% | 29.1% | 28.7% |
| Operating margin | 10.9% | 9.9% | 9.2% | 13.8% | 11.4% | 9.8% | 7.1% | 8.6% | 10.0% | 9.8% |
| EBITDA margin | 16.9% | 16.1% | 15.5% | 20.4% | 18.7% | 17.2% | 13.6% | 14.4% | 16.0% | 16.2% |
| Net margin | β0.1% | 0.9% | 7.5% | 2.2% | 0.0% | 3.4% | 12.9% | 4.3% | 4.6% | 4.1% |
| FCF margin | 7.6% | 3.8% | 7.9% | 7.3% | 8.3% | 8.0% | 2.2% | 6.4% | 6.3% | 6.0% |
| Returns | ||||||||||
| Return on capital | 6.6% | 4.5% | 6.4% | 8.5% | 4.8% | 4.1% | 4.4% | 4.9% | 6.2% | 5.7% |
| Return on capital employed | 6.3% | 5.2% | 4.9% | 6.7% | 4.8% | 4.3% | 3.8% | 5.6% | 7.0% | 6.6% |
| Return on equity | β0.1% | 1.7% | 16.0% | 4.2% | 0.0% | 6.0% | 25.2% | 8.5% | 9.3% | 8.6% |
| Return on assets | β0.0% | 0.5% | 3.8% | 1.0% | 0.0% | 1.4% | 6.4% | 2.6% | 3.0% | 2.5% |
| Growth | ||||||||||
| Revenue growth | 8.2% | 4.0% | 19.7% | β9.2% | β17.1% | 5.7% | 17.5% | 19.5% | 13.3% | 3.0% |
| Net income growth | β | β | 867.5% | β73.3% | β99.4% | 20,737.5% | 353.9% | β60.2% | 21.7% | β8.5% |
| EPS growth | β | β | 1,132.0% | β73.1% | β99.4% | 23,700.0% | 408.0% | β60.1% | 17.0% | β2.3% |
| FCF growth | 10.8% | β48.5% | 151.5% | β16.1% | β5.1% | 1.1% | β68.0% | 251.4% | 12.3% | β2.8% |
| Share count change | 21.3% | 1.6% | 8.6% | β1.1% | β8.3% | β5.2% | β4.0% | 6.9% | β0.2% | β6.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | 4.0x | 6.8x | 6.5x | 5.2x | 6.7x | 6.8x | 6.8x | 5.9x | 4.8x | 5.5x |
| Debt / equity | 1.5x | 2.6x | 2.4x | 2.4x | 2.5x | 2.4x | 1.8x | 1.6x | 1.7x | 2.0x |
| Interest coverage | 1.8x | 1.6x | 1.5x | 2.4x | 1.6x | 1.5x | 1.3x | 2.2x | 2.5x | 2.2x |
| Current ratio | 3.3x | 3.7x | 2.8x | 2.7x | 2.4x | 2.0x | 2.7x | 1.8x | 2.4x | 1.7x |
| Quick ratio | 2.5x | 2.9x | 2.2x | 1.9x | 1.7x | 1.5x | 2.0x | 0.9x | 1.6x | 1.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.4% | 3.6% | 3.6% | 4.8% | 4.9% | 3.8% | 4.4% | 4.3% | 5.4% | 6.3% |
| Stock comp / revenue | 0.3% | 0.5% | 0.5% | 0.7% | 0.9% | 1.0% | 1.1% | 1.1% | 1.1% | 1.0% |
| Payouts / FCF | 3.8% | 161.9% | 44.3% | 77.8% | 149.9% | 100.0% | 348.0% | 86.5% | 59.9% | 145.3% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 6.0 | 5.0 | 6.0 | 4.0 | 7.0 | 7.0 | 5.0 | 8.0 | 4.0 |
| Altman Z'' | 1.8 | 1.6 | 1.4 | 1.6 | 1.4 | 1.2 | 1.8 | 1.6 | 2.0 | 1.7 |
| Accruals ratio | β5.5% | β3.2% | β2.0% | β4.5% | β5.2% | β3.4% | 3.2% | β3.9% | β4.6% | β5.0% |
Source: SEC EDGAR XBRL filings (CIK 0001530950). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.